Literature DB >> 8329511

Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991.

B Demers1, A E Simor, H Vellend, P M Schlievert, S Byrne, F Jamieson, S Walmsley, D E Low.   

Abstract

During the past few years, there has been an apparent increase in serious infections due to group A streptococci (GAS) worldwide. We describe our experience with severe invasive GAS infections in Ontario, Canada, during the past 5 years (February 1987 through December 1991). A case was defined as the isolation of GAS from blood or normally sterile tissue in association with hypotension (systolic blood pressure, < 90 mm Hg). Fifty cases were identified in patients ranging in age from 4 to 100 years (median age, 47 years); 29 (58%) of the patients died. A primary focus of infection was identified in 38 cases (76%), with soft tissue being the site involved most frequently (68%). No focus of infection was found in 12 patients, and 36 patients (72%) were bacteremic. Complications included acute respiratory distress syndrome (21 of 50), acute renal failure (20 of 50), hypocalcemia (19 of 24), elevated creatinine kinase values (21 of 27), coagulation abnormalities (15 of 21), and hepatitis (15 of 24). Eleven cases (22%) were nosocomial; one of these was secondary to another nosocomial case. Thirty-three isolates were available for M and T typing and for determination of the presence of the genes for streptococcal pyrogenic exotoxin (SPE). The most frequent types were M1T1 (10) and M12/T12 (8). Twelve isolates possessed the speA gene, and 16 isolates had the speC gene. Only three isolates possessed both speA and speC. All isolates possessed the speB gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329511     DOI: 10.1093/clind/16.6.792

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Betty Forwick; Nancy P Hoe; James M Musser; James A Talbot
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Poststreptococcal arthritis.

Authors: 
Journal:  Can J Infect Dis       Date:  1995-05

3.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

4.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

5.  Identification of group A Streptococcus antigenic determinants upregulated in vivo.

Authors:  Kowthar Y Salim; Dennis G Cvitkovitch; Peter Chang; Darrin J Bast; Martin Handfield; Jeffrey D Hillman; Joyce C S de Azavedo
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 6.  Necrotising fasciitis: a new management algorithm based on clinical classification.

Authors:  Paul S Carter; Paul E Banwell
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

7.  The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection.

Authors:  Shigefumi Okamoto; Shigetada Kawabata; Yutaka Terao; Hideaki Fujitaka; Yoshinobu Okuno; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Host Genetic Variations and Sex Differences Potentiate Predisposition, Severity, and Outcomes of Group A Streptococcus-Mediated Necrotizing Soft Tissue Infections.

Authors:  Karthickeyan Chella Krishnan; Santhosh Mukundan; Jeyashree Alagarsamy; Donna Laturnus; Malak Kotb
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

9.  Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.

Authors:  S M Kuhn; J Preiksaitis; G J Tyrrel; T Jadavji; D Church; H D Davies
Journal:  Can J Infect Dis       Date:  2001-01

10.  Population-based surveillance of invasive group A streptococcal disease in British Columbia: 1996 to 1998.

Authors:  G L Bjorson; D W Scheifele; A Bell; A King
Journal:  Can J Infect Dis       Date:  2001-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.